Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:28666451

Autologous chondrocyte implantation-derived synovial fluids display distinct responder and non-responder proteomic profiles.

Charlotte H Hulme · Emma L Wilson · Mandy J Peffers · Sally Roberts · Deborah M Simpson · James B Richardson · Pete Gallacher · Karina T Wright

Arthritis research & therapy · 2017 doi:10.1186/s13075-017-1336-7

Paper

complete

Experiment

complete

Data

partial

Analysis

complete

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:28666451
kind
science-record
content_hash
sha256:25a27d8fc49ad2af30885baa8bb7d3289d42000038900a08dc35d78b4a1ef3c8
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:40:27Z
updated_at
2026-11-01T22:43:02Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Autologous chondrocyte implantation-derived synovial fluids display distinct responder and non-responder proteomic profiles.
doi
10.1186/s13075-017-1336-7
pmid
28666451
authors array · 8 items
[0]
Charlotte H Hulme
[1]
Emma L Wilson
[2]
Mandy J Peffers
[3]
Sally Roberts
[4]
Deborah M Simpson
[5]
James B Richardson
[6]
Pete Gallacher
[7]
Karina T Wright
journal
Arthritis research & therapy
year
2017
abstract
BACKGROUND: Autologous chondrocyte implantation (ACI) can be used in the treatment of focal cartilage injuries to prevent the onset of osteoarthritis (OA). However, we are yet to understand fully why some individuals do not respond well to this intervention. Identification of a reliable and accurate biomarker panel that can predict which patients are likely to respond well to ACI is needed in order to assign the patient to the most appropriate therapy. This study aimed to compare the baseline and mid-treatment proteomic profiles of synovial fluids (SFs) obtained from responders and non-responders to ACI. METHODS: SFs were derived from 14 ACI responders (mean Lysholm improvement of 33 (17-54)) and 13 non-responders (mean Lysholm decrease of 14 (4-46)) at the two stages of surgery (cartilage harvest and chondrocyte implantation). Label-free proteome profiling of dynamically compressed SFs was used to identify predictive markers of ACI success or failure and to investigate the biological pathways involved in the clinical response to ACI. RESULTS: Only 1 protein displayed a ≥2.0-fold differential abundance in the preclinical SF of ACI responders versus non-responders. However, there is a marked difference between these two groups with regard to their proteome shift in response to cartilage harvest, with 24 and 92 proteins showing ≥2.0-fold differential abundance between Stages I and II in responders and non-responders, respectively. Proteomic data has been uploaded to ProteomeXchange (identifier: PXD005220). We have validated two biologically relevant protein changes associated with this response, demonstrating that matrix metalloproteinase 1 was prominently elevated and S100 calcium binding protein A13 was reduced in response to cartilage harvest in non-responders. CONCLUSIONS: The differential proteomic response to cartilage harvest noted in responders versus non-responders is completely novel. Our analyses suggest several pathways which appear to be altered in non-responders that are worthy of further investigation to elucidate the mechanisms of ACI failure. These protein changes highlight many putative biomarkers that may have potential for prediction of ACI treatment success.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
Statistical analysis was performed using ProgenesisQI™ software; briefly transformed normalised abundances were used for one-way analysis of variance (ANOVA) and all peptides (with p < 0.05) of an identified protein were included.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:28666451
locator
sections[6] "Mass spectrometry and label-free quantification" paragraph 2
quote
Statistical analysis was performed using ProgenesisQI™ software; briefly transformed normalised abundances were used for one-way analysis of variance (ANOVA) and all peptides (with p < 0.05) of an identified protein were included.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
Proteomic data has been deposited in the PRIDE ProteomeXchange and can be accessed using the identifier PXD005220.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:28666451
locator
sections[17] "ack" paragraph 1
quote
Proteomic data has been deposited in the PRIDE ProteomeXchange and can be accessed using the identifier PXD005220.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
The study used Ingenuity pathway analysis with a right-sided Fisher’s exact test and an independent DAVID pathway analysis, while the underlying proteomic source data were deposited in PRIDE ProteomeXchange under identifier PXD005220.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:28666451
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD005220
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD005220
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 6 items
[0] object · 15 fields
id
source:pmid:28666451
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1186/s13075-017-1336-7
sha256
sha256:c098eae219b4c813614ad855bcebd23e82a42d28d0f8493f76b2eef7501212f2
bytes
50158
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1186/s13075-017-1336-7
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC5493128
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:PXD005220
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD005220
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
PXD005220
version
null
note
Proteomic data has been deposited in the PRIDE ProteomeXchange and can be accessed using the identifier PXD005220.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
Proteomic data has been deposited in the PRIDE ProteomeXchange and can be accessed using the identifier PXD005220.
access_statement_kind
data_availability_statement
sample_accessions array · 0 items
sample_count
null
group_sizes
null
group_sizes_basis
null
platform
null
taxon
null
title
Proteomic profiles of synovial fluids derived from autologous chondrocyte implantation surgery
resolution_checked_at
2026-10-31T18:35:55Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 16 fields
id
asset:table:pmid:28666451:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:bc4afaf837a5d76c20b6ba7a8a43906f9d8bec36a19036c13386050a7233c8ea
bytes
1940
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[3]/table-wrap[1]#Tab1
version
null
note
Demographic data for patient participants whose samples from Stage I or Stage II were analysed who responded clinically (responders) or who did not respond (non-responders) to autologous chondrocyte implantation (ACI)
structure object · 5 fields
pmcid
PMC5493128
section_index
3
section_title
Synovial fluid collection and storage
row_count
16
column_count
7
table object · 8 fields
label
Table 1
caption
Demographic data for patient participants whose samples from Stage I or Stage II were analysed who responded clinically (responders) or who did not respond (non-responders) to autologous chondrocyte implantation (ACI)
rows array · 16 items
[0] array · 5 items
[0]
[1]
Stage I
[2]
Stage II
[3]
p value (A) R v NR SI; (B) R v NR SI
[4]
p value (A) SI v SII R; (B) SI v SII NR
[1] array · 4 items
[0]
Responders (n = 8)
[1]
Non-responders (n = 7)
[2]
Responders (n = 12)
[3]
Non-responders (n = 12)
[2] array · 7 items
[0]
Difference in Lysholm Score
[1]
27 (17–38)
[2]
–8 (–4 to –17)
[3]
34 (17–54)
[4]
–11 (–4 to –46)
[5]
(A) 0.0003; (B) <0.0001
[6]
(A) 0.21; (B) 0.55
[3] array · 7 items
[0]
BMI (kg/m2)
[1]
29 (23–31)
[2]
27 (24–31)
[3]
27 (23–48)
[4]
29 (22–36)
[5]
(A) 0.94; (B) 0.54
[6]
(A) 0.73; (B) 0.68
[4] array · 7 items
[0]
Age (years)
[1]
32 (17–49)
[2]
40 (25–50)
[3]
40 (17–90)
[4]
43 (25–52)
[5]
(A) 0.28; (B) 0.92
[6]
(A) 0.17; (B) 0.58
[5] array · 7 items
[0]
Male (n)
[1]
8
[2]
7
[3]
11
[4]
10
[5]
(A) >0.99; (B) >0.99
[6]
(A) >0.99; (B) 0.51
[6] array · 7 items
[0]
Smoker (n)
[1]
1
[2]
2
[3]
1
[4]
3
[5]
(A) 0.54; (B) 0.59
[6]
(A) >0.99; (B) >0.99
[7] array · 7 items
[0]
Dilution factor of SF
[1]
5 (3–9)
[2]
4 (2–7)
[3]
4 (1–9)
[4]
3 (2–5)
[5]
(A) 0.48; (B) 0.25
[6]
(A) 0.53; (B) 0.50
[8] array · 7 items
[0]
Total defect area (cm2)
[1]
14 (0.4–24)
[2]
6 (0.6–12)
[3]
6 (1–20)
[4]
5 (0.6–12)
[5]
(A) 0.74; (B) 0.35
[6]
(A) 0.45; (B) 0.28
[9] array · 7 items
[0]
Patella defect (n)
[1]
1
[2]
1
[3]
4
[4]
2
[5]
(A) >0.99; (B) 0.64
[6]
(A) 0.60; (B) >0.99
[10] array · 7 items
[0]
LFC defect (n)
[1]
2
[2]
0
[3]
0
[4]
0
[5]
(A) 0.47; (B) >0.99
[6]
(A) 0.15; (B) >0.99
[11] array · 7 items
[0]
LTP defect (n)
[1]
1
[2]
0
[3]
0
[4]
0
[5]
(A) >0.99; (B) >0.99
[6]
(A) 0.15; (B) >0.99
[12] array · 7 items
[0]
MFC defect (n)
[1]
2
[2]
2
[3]
1
[4]
6
[5]
(A) >0.99; (B) 0.07
[6]
(A) 0.54; (B) 0.63
[13] array · 7 items
[0]
Trochlea defect (n)
[1]
0
[2]
3
[3]
2
[4]
1
[5]
(A) 0.20; (B) >0.99
[6]
(A) 0.49; (B) 0.12
[14] array · 7 items
[0]
Multiple defects (n)
[1]
1
[2]
0
[3]
1
[4]
1
[5]
(A) >0.99; (B) >0.99
[6]
(A) >0.99; (B) >0.99
[15] array · 7 items
[0]
Unknown defect location (n)
[1]
1
[2]
1
[3]
4
[4]
2
[5]
(A) >0.99; (B) 0.64
[6]
(A) 0.60; (B) >0.99
locator
section[3]/table-wrap[1]#Tab1
[3] object · 16 fields
id
asset:table:pmid:28666451:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:07b8c536a67e4cb2f70a7a828f3e6ff710462df9488e9ff9eba3142c1275cb21
bytes
5011
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[11]/table-wrap[1]#Tab2
version
null
note
Fold-change of proteins that are differentially expressed in the synovial fluid collected at Stage I compared to Stage II of the ACI procedure in clinical non-responders. Proteins shown in italic were validated using enzyme linked immunosorbant assay
structure object · 5 fields
pmcid
PMC5493128
section_index
11
section_title
Differential abundance of proteins after controlled cartilage injury (Stage I versus Stage II)
row_count
91
column_count
3
table object · 8 fields
label
Table 2
caption
Fold-change of proteins that are differentially expressed in the synovial fluid collected at Stage I compared to Stage II of the ACI procedure in clinical non-responders. Proteins shown in italic were validated using enzyme linked immunosorbant assay
rows array · 91 items
[0] array · 2 items
[0]
Protein
[1]
Fold change
[1] array · 2 items
[0]
Description
[1]
Accession
[2] array · 3 items
[0]
Perilipin-4
[1]
Q96Q06
[2]
–4.3
[3] array · 3 items
[0]
Syntaxin-7
[1]
O15400
[2]
–3.9
[4] array · 3 items
[0]
Fermitin family homolog 3
[1]
Q86UX7
[2]
–3.7
[5] array · 3 items
[0]
Deoxynucleoside triphosphate triphosphohydrolase SAMHD1
[1]
Q9Y3Z3
[2]
–3.7
[6] array · 3 items
[0]
PDZ and LIM domain protein 1
[1]
O00151
[2]
–3.6
[7] array · 3 items
[0]
Sorting nexin-5
[1]
Q9Y5X3
[2]
–3.3
[8] array · 3 items
[0]
Neuroblast differentiation-associated protein AHNAK
[1]
Q09666
[2]
–3.2
[9] array · 3 items
[0]
Signal recognition particle 14 kDa protein
[1]
P37108
[2]
–3.0
[10] array · 3 items
[0]
Hyaluronan and proteoglycan link protein 3
[1]
Q96S86
[2]
–3.0
[11] array · 3 items
[0]
Heterogeneous nuclear ribonucleoprotein K
[1]
P61978
[2]
–2.9
[12] array · 3 items
[0]
ATP-citrate synthase
[1]
P53396
[2]
–2.9
[13] array · 3 items
[0]
Fatty acid-binding protein, epidermal
[1]
Q01469
[2]
–2.8
[14] array · 3 items
[0]
60S ribosomal protein L12
[1]
P30050
[2]
–2.7
[15] array · 3 items
[0]
Fatty acid-binding protein, adipocyte
[1]
P15090
[2]
–2.6
[16] array · 3 items
[0]
Insulin-like growth factor-binding protein 6
[1]
P24592
[2]
–2.6
[17] array · 3 items
[0]
Protein canopy homolog 3
[1]
Q9BT09
[2]
–2.6
[18] array · 3 items
[0]
Tripeptidyl-peptidase 1
[1]
O14773
[2]
–2.5
[19] array · 3 items
[0]
PDZ and LIM domain protein 3
[1]
Q53GG5
[2]
–2.5
[20] array · 3 items
[0]
Cellular nucleic acid-binding protein
[1]
P62633
[2]
–2.5
[21] array · 3 items
[0]
Bifunctional glutamate/proline-tRNA ligase
[1]
P07814
[2]
–2.5
[22] array · 3 items
[0]
Protein disulfide-isomerase A3
[1]
P30101
[2]
–2.4
[23] array · 3 items
[0]
Peroxiredoxin-6
[1]
P30041
[2]
–2.4
[24] array · 3 items
[0]
Tryptase alpha/beta-1
[1]
Q15661
[2]
–2.4
[25] array · 3 items
[0]
Endoplasmic reticulum resident protein 29
[1]
P30040
[2]
–2.4
[26] array · 3 items
[0]
Peroxiredoxin-1
[1]
Q06830
[2]
–2.4
[27] array · 3 items
[0]
Na(+)/H(+) exchange regulatory cofactor NHE-RF1
[1]
O14745
[2]
–2.4
[28] array · 3 items
[0]
Mitochondrial import inner membrane translocase subunit TIM14
[1]
Q96DA6
[2]
–2.4
[29] array · 3 items
[0]
Mortality factor 4-like protein 1
[1]
Q9UBU8
[2]
–2.4
[30] array · 3 items
[0]
Fructose-bisphosphate aldolase A
[1]
P04075
[2]
–2.3
[31] array · 3 items
[0]
Microtubule-associated protein RP/EB family member 1
[1]
Q15691
[2]
–2.3
[32] array · 3 items
[0]
Leucine zipper transcription factor-like protein 1
[1]
Q9NQ48
[2]
–2.3
[33] array · 3 items
[0]
Transcription elongation factor A protein 1
[1]
P23193
[2]
–2.3
[34] array · 3 items
[0]
2',3'-cyclic-nucleotide 3'-phosphodiesterase
[1]
P09543
[2]
–2.3
[35] array · 3 items
[0]
Histamine N-methyltransferase
[1]
P50135
[2]
–2.3
[36] array · 3 items
[0]
Protein S100-A13
[1]
Q99584
[2]
–2.3
[37] array · 3 items
[0]
Acrosomal protein SP-10
[1]
P26436
[2]
–2.2
[38] array · 3 items
[0]
AP-2 complex subunit beta
[1]
P63010
[2]
–2.2
[39] array · 3 items
[0]
S-phase kinase-associated protein 1
[1]
P63208
[2]
–2.2
[40] array · 3 items
[0]
High mobility group protein B3
[1]
O15347
[2]
–2.2
[41] array · 3 items
[0]
Cytokine-like protein 1
[1]
Q9NRR1
[2]
–2.2
[42] array · 3 items
[0]
Mitochondrial fission 1 protein
[1]
Q9Y3D6
[2]
–2.2
[43] array · 3 items
[0]
Filamin-A
[1]
P21333
[2]
–2.2
[44] array · 3 items
[0]
Nuclear migration protein nudC
[1]
Q9Y266
[2]
–2.1
[45] array · 3 items
[0]
Cathepsin K
[1]
P43235
[2]
–2.1
[46] array · 3 items
[0]
Prostaglandin E synthase 3
[1]
Q15185
[2]
–2.1
[47] array · 3 items
[0]
Vinculin
[1]
P18206
[2]
–2.1
[48] array · 3 items
[0]
Plastin-2
[1]
P13796
[2]
–2.1
[49] array · 3 items
[0]
Coronin-1C
[1]
Q9ULV4
[2]
–2.1
[50] array · 3 items
[0]
Ig heavy chain V-I region V35
[1]
P23083
[2]
–2.1
[51] array · 3 items
[0]
Stress-induced-phosphoprotein 1
[1]
P31948
[2]
–2.1
[52] array · 3 items
[0]
Putative phospholipase B-like 2
[1]
Q8NHP8
[2]
–2.1
[53] array · 3 items
[0]
Gelsolin
[1]
P06396
[2]
–2.0
[54] array · 3 items
[0]
Spectrin beta chain, erythrocytic
[1]
P11277
[2]
–2.0
[55] array · 3 items
[0]
Stathmin
[1]
P16949
[2]
–2.0
[56] array · 3 items
[0]
Hsc70-interacting protein
[1]
P50502
[2]
–2.0
[57] array · 3 items
[0]
40S Ribosomal protein
[1]
P23396
[2]
–2.0
[58] array · 3 items
[0]
Epidermal growth factor receptor substrate 15
[1]
P42566
[2]
22.5
[59] array · 3 items
[0]
Hemoglobin subunit theta-1
[1]
P09105
[2]
6.1
[60] array · 3 items
[0]
C-type lectin domain family 11 member A
[1]
Q9Y240
[2]
5.6
[61] array · 3 items
[0]
Periostin
[1]
Q15063
[2]
5.1
[62] array · 3 items
[0]
Collagen alpha-1(I) chain
[1]
P02452
[2]
4.7
[63] array · 3 items
[0]
Spectrin alpha chain, erythrocytic 1
[1]
P02549
[2]
4.0
[64] array · 3 items
[0]
Collagen alpha-1(V) chain
[1]
P20908
[2]
3.7
[65] array · 3 items
[0]
Fibrinogen gamma chain
[1]
P02679
[2]
3.5
[66] array · 3 items
[0]
Collagen alpha-1(XII) chain
[1]
Q99715
[2]
3.3
[67] array · 3 items
[0]
Complement C1q tumor necrosis factor-related protein 3
[1]
Q9BXJ4
[2]
3.1
[68] array · 3 items
[0]
Adiponectin
[1]
Q15848
[2]
3.0
[69] array · 3 items
[0]
Adipocyte enhancer-binding protein 1
[1]
Q8IUX7
[2]
3.0
[70] array · 3 items
[0]
Latent-transforming growth factor beta-binding protein 1
[1]
Q14766
[2]
3.0
[71] array · 3 items
[0]
Fibrinogen beta chain
[1]
P02675
[2]
3.0
[72] array · 3 items
[0]
Chondroitin sulfate proteoglycan 4
[1]
Q6UVK1
[2]
2.9
[73] array · 3 items
[0]
Fibrinogen alpha chain
[1]
P02671
[2]
2.8
[74] array · 3 items
[0]
Interstitial collagenase (MMP1)
[1]
P03956
[2]
2.7
[75] array · 3 items
[0]
Secreted phosphoprotein 24
[1]
Q13103
[2]
2.7
[76] array · 3 items
[0]
Collagen alpha-2(V) chain
[1]
P05997
[2]
2.6
[77] array · 3 items
[0]
Ferritin light chain
[1]
P02792
[2]
2.6
[78] array · 3 items
[0]
C4b-binding protein alpha chain
[1]
P04003
[2]
2.6
[79] array · 3 items
[0]
Nucleobindin-1
[1]
Q02818
[2]
2.4
[80] array · 3 items
[0]
C4b-binding protein beta chain
[1]
P20851
[2]
2.2
[81] array · 3 items
[0]
Vitamin K-dependent protein S
[1]
P07225
[2]
2.2
[82] array · 3 items
[0]
Fibronectin
[1]
P02751
[2]
2.2
[83] array · 3 items
[0]
Prosaposin
[1]
P07602
[2]
2.1
[84] array · 3 items
[0]
Integrin beta-like protein 1
[1]
O95965
[2]
2.1
[85] array · 3 items
[0]
Adipocyte plasma membrane-associated protein
[1]
Q9HDC9
[2]
2.1
[86] array · 3 items
[0]
Cytoplasmic dynein 1 heavy chain 1
[1]
Q14204
[2]
2.0
[87] array · 3 items
[0]
Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D
[1]
A1L4H1
[2]
2.0
[88] array · 3 items
[0]
F-actin-capping protein subunit beta
[1]
P47756
[2]
2.0
[89] array · 3 items
[0]
Mannan-binding lectin serine protease 1
[1]
P48740
[2]
2.0
[90] array · 3 items
[0]
Thrombospondin-3
[1]
P49746
[2]
2.0
locator
section[11]/table-wrap[1]#Tab2
[4] object · 16 fields
id
asset:table:pmid:28666451:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:7aa5cdfc8280ec6a4158f1aa502218a473efd4500b5f6ef865567c4299dbb959
bytes
1577
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[11]/table-wrap[2]#Tab3
version
null
note
Proteins that are differentially expressed with a ≥2.0-fold-change in the synovial fluid collected at Stage I compared to Stage II of the ACI procedure in clinical responders
structure object · 5 fields
pmcid
PMC5493128
section_index
11
section_title
Differential abundance of proteins after controlled cartilage injury (Stage I versus Stage II)
row_count
26
column_count
3
table object · 8 fields
label
Table 3
caption
Proteins that are differentially expressed with a ≥2.0-fold-change in the synovial fluid collected at Stage I compared to Stage II of the ACI procedure in clinical responders
rows array · 26 items
[0] array · 2 items
[0]
Protein
[1]
Fold change
[1] array · 2 items
[0]
Description
[1]
Accession
[2] array · 3 items
[0]
Heat shock protein 75 kDa, mitochondrial
[1]
Q12931
[2]
–470.0
[3] array · 3 items
[0]
Microtubule-associated protein 1B
[1]
P46821
[2]
–17.2
[4] array · 3 items
[0]
Adenosylhomocysteinase
[1]
P23526
[2]
–3.7
[5] array · 3 items
[0]
Complement factor H-related protein 3
[1]
Q02985
[2]
–2.8
[6] array · 3 items
[0]
Mannose-1-phosphate guanyltransferase beta
[1]
Q9Y5P6
[2]
–2.7
[7] array · 3 items
[0]
Peroxiredoxin-4
[1]
Q13162
[2]
–2.5
[8] array · 3 items
[0]
Oxysterol-binding protein 1
[1]
P22059
[2]
–2.4
[9] array · 3 items
[0]
Protein canopy homolog 3
[1]
Q9BT09
[2]
–2.1
[10] array · 3 items
[0]
Spermatid perinuclear RNA-binding protein
[1]
Q96SI9
[2]
–2.0
[11] array · 3 items
[0]
Ferritin light chain
[1]
P02792
[2]
2.2
[12] array · 3 items
[0]
Secreted phosphoprotein 24
[1]
Q13103
[2]
2.2
[13] array · 3 items
[0]
Chondroitin sulfate proteoglycan 4
[1]
Q6UVK1
[2]
2.3
[14] array · 3 items
[0]
Collagen alpha-2(I) chain
[1]
P08123
[2]
2.3
[15] array · 3 items
[0]
Collagen alpha-1(V) chain
[1]
P20908
[2]
2.5
[16] array · 3 items
[0]
26S protease regulatory subunit 6A
[1]
P17980
[2]
2.7
[17] array · 3 items
[0]
Collagen alpha-2(V) chain
[1]
P05997
[2]
2.9
[18] array · 3 items
[0]
Collagen alpha-1(I) chain
[1]
P02452
[2]
3.3
[19] array · 3 items
[0]
Spectrin alpha chain, erythrocytic 1
[1]
P02549
[2]
4.1
[20] array · 3 items
[0]
Histidine triad nucleotide-binding protein 1
[1]
P49773
[2]
4.2
[21] array · 3 items
[0]
Platelet factor 4
[1]
P02776
[2]
4.2
[22] array · 3 items
[0]
Alpha-1-acid glycoprotein 2
[1]
P19652
[2]
4.3
[23] array · 3 items
[0]
Protein 4.1
[1]
P11171
[2]
4.3
[24] array · 3 items
[0]
Periostin
[1]
Q15063
[2]
4.5
[25] array · 3 items
[0]
26S proteasome non-ATPase regulatory subunit 13
[1]
Q9UNM6
[2]
4.6
locator
section[11]/table-wrap[2]#Tab3
[5] object · 16 fields
id
asset:table:pmid:28666451:4
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:2199179b97fa41a5fd60b7dcf5cfc145981c31f82a8e5150228d816341d5dbaf
bytes
2352
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[12]/table-wrap[1]#Tab4
version
null
note
Analysis of upstream regulators of interactome networks generated from protein changes between Stages I (SI) and II (SII) in either responders or non-responders to ACI were identified using Ingenuity Pathway Analysis software
structure object · 5 fields
pmcid
PMC5493128
section_index
12
section_title
Identification of canonical pathways and protein networks associated with protein changes between Stage I and II
row_count
23
column_count
5
table object · 8 fields
label
Table 4
caption
Analysis of upstream regulators of interactome networks generated from protein changes between Stages I (SI) and II (SII) in either responders or non-responders to ACI were identified using Ingenuity Pathway Analysis software
rows array · 23 items
[0] array · 4 items
[0]
Upstream regulators
[1]
Activation z score (SII v SI)
[2]
p value of overlap
[3]
Target molecules in dataset
[1] array · 1 item
[0]
Non-responders
[2] array · 5 items
[0]
[1]
TGFB1
[2]
–1.595
[3]
9.46E–10
[4]
APOB,APOC2,APOE,CD44,COL1A1,COL1A2,COL5A1,COMP,CSPG4,CTSD,ECM1,FETUB,FN1,FTL,GSN,HINT1,HSPG2,HTRA1,IGFBP6,LCAT,MYLK,PCOLCE2,PDXK,POSTN,RAP1A,S100A4,TGFBI
[3] array · 4 items
[0]
DYSF
[1]
NP
[2]
2.01E–09
[3]
CFD,FN1,FTL,LCP1,LYZ,PROS1,S100-A13,S100A4
[4] array · 4 items
[0]
MYC
[1]
3.046
[2]
2.20E–09
[3]
ALDOA,ANXA5,CCT3,CD44,COL1A1,COL1A2,COL5A1,CSPG4,CTSD,ECM1,FN1,HSPA9,LYZ,NCL,NUCB1,NUDC,PAM,PTN,RPL22,RPL30,TF
[5] array · 4 items
[0]
COL9A1
[1]
1.308
[2]
2.79E–09
[3]
COMP,FN1,HSPG2,TGFBI,THBS4
[6] array · 4 items
[0]
Beta-estradiol
[1]
2.271
[2]
5.01E–09
[3]
ALDOA,APOE,CD44,COL1A1,COL1A2,COMP,CTSD,F7,FN1,GMFB,HSPA2,HSPA8,HSPA9,HTRA1,IGFBP6,LTF,LYZ,MYLK,PAM,PDIA3,QSOX1,RAP1A,RPS13,S100-A13,SLC9A3R1,TF,THBS4
[7] array · 4 items
[0]
Lipopolysaccharide
[1]
–0.104
[2]
5.96E–09
[3]
ANXA5,APOB,APOC2,APOE,CD44,CFD,COL1A1,COL1A2,COL5A1,CSPG4,FN1,GSN,HDGFRP3,HMGB2,HSPA8,HTRA1,ITIH2,LBP,LTF,LYZ,PARK7,PCOLCE,PCOLCE2,PDIA3,PLG,TF
[8] array · 4 items
[0]
Dihydrotestosterone
[1]
–1.091
[2]
1.03E–08
[3]
ALDOA,APOE,CCT3,FN1,FTL,GSN,HINT1,LYZ,MYLK,NUCB1,PAM,POSTN,PROS1,RPL30,TF
[9] array · 4 items
[0]
HRAS
[1]
0.623
[2]
2.52E–08
[3]
CD44,COL1A1,COL1A2,ERP29,FN1,GSN,HSPA8,HTRA1,LYZ,MYH10,PDIA5,PLTP,POSTN,RPL30,S100A4
[10] array · 4 items
[0]
KRAS
[1]
2.226
[2]
3.99E–08
[3]
ALDOA,CD44,COL1A1,FN1,GBA,GSN,MYLK,PCOLCE,PDIA3,PSMA7,RNASE4,S100A4
[11] array · 4 items
[0]
SMARCB1
[1]
–1.195
[2]
4.82E–08
[3]
APOC4,CD44,COL1A1,COL1A2,GSN,LBP,POSTN,PTN,RAB14
[12] array · 1 item
[0]
Responders
[13] array · 5 items
[0]
[1]
CEBPB
[2]
–1.067
[3]
2.03E–07
[4]
APOB,CFD,COL1A1,COL1A2,F7,HSPA8,PLG
[14] array · 4 items
[0]
FLI1
[1]
NP
[2]
3.82E–07
[3]
COL1A1,COL1A2,HSPA8,PF4
[15] array · 4 items
[0]
S-adenosylhomocysteine
[1]
NP
[2]
1.21E–06
[3]
COL1A1,COL1A2
[16] array · 4 items
[0]
SCX
[1]
NP
[2]
1.65E–06
[3]
COL1A1,COMP,POSTN
[17] array · 4 items
[0]
Tgf beta (group)
[1]
–1.454
[2]
5.16E–06
[3]
COL1A1,COL1A2,LCAT,POSTN,TGFBI
[18] array · 4 items
[0]
ENTPD5
[1]
NP
[2]
1.21E–05
[3]
COL1A1,COL1A2
[19] array · 4 items
[0]
MKX
[1]
NP
[2]
1.21E–05
[3]
COL1A1,COL1A2
[20] array · 4 items
[0]
GATA4
[1]
NP
[2]
2.86E–05
[3]
COL1A1,COL1A2,POSTN,TGFBI
[21] array · 4 items
[0]
Nilotinib
[1]
NP
[2]
3.39E–05
[3]
COL1A1,COL1A2
[22] array · 4 items
[0]
TBX5
[1]
NP
[2]
5.50E–05
[3]
COL1A1,COL1A2,POSTN
locator
section[12]/table-wrap[1]#Tab4
gaps array · 2 items
[0]
asset:data:geo:PXD005220 not downloaded
[1]
asset:data:geo:PXD005220 licence not read
analysis object · 4 fields
state
complete
methods array · 2 items
[0] object · 10 fields
id
method-1
family
group_comparison
specific
anova
label
Group comparison
dsl_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
1
band
verbatim
quote
Statistical analysis was performed using ProgenesisQI™ software; briefly transformed normalised abundances were used for one-way analysis of variance (ANOVA) and all peptides (with p < 0.05) of an identified protein were included.
[1] object · 10 fields
id
method-2
family
network_analysis
specific
pathway_enrichment
label
Network / pathway analysis
dsl_operations array · 1 item
[0]
pathway_enrich
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
edge_list
evidence object · 3 fields
score
0.8
band
high
quote
pathway enrichment
targets array · 1 item
[0] object · 8 fields
id
target-published-estimate
claim_id
claim-target-result
operation
bootstrap_mean_difference
unit
p-value
tolerance
null
state
complete
note
The threshold the paper applied to its own result, as the paper states it. A run that reproduces the effect is judged against this threshold.
gaps array · 0 items
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: anova.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
PXD005220
resolved_accessions array · 1 item
[0]
PXD005220
statements array · 1 item
[0]
Proteomic data has been deposited in the PRIDE ProteomeXchange and can be accessed using the identifier PXD005220.
basis
The paper names PXD005220 in PRIDE ProteomeXchange and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
assets array · 6 items
[0]
source:pmid:28666451
[1]
data:geo:PXD005220
[2]
asset:table:pmid:28666451:1
[3]
asset:table:pmid:28666451:2
[4]
asset:table:pmid:28666451:3
[5]
asset:table:pmid:28666451:4
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:PXD005220
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:31:28Z
independence
same_provider
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
8
usage object · 3 fields
prompt_tokens
105032
completion_tokens
2881
cached_tokens
2088
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:28666451
type
paper
label
pmid:28666451
[1] object · 3 fields
id
source:pmid:28666451
type
manuscript
label
PMID 28666451 full text
[2] object · 3 fields
id
data:geo:PXD005220
type
dataset
label
GEO PXD005220
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:28666451
type
paper
label
pmid:28666451
[1] object · 3 fields
id
source:pmid:28666451
type
manuscript
label
PMID 28666451 full text
[2] object · 3 fields
id
data:geo:PXD005220
type
dataset
label
GEO PXD005220
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-28666451
type
extraction
used array · 1 item
[0]
source:pmid:28666451
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-PXD005220
type
accession_resolution
used array · 1 item
[0]
data:geo:PXD005220
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:28666451
parent_hash
sha256:06d57e8314c43768ce1fa11cdd5e00434978fd45123cab063d0ed06530f36a16
fork_of
null
gaps array · 6 items
[0]
asset:data:geo:PXD005220 licence not read
[1]
asset:data:geo:PXD005220 not downloaded
[2]
execution.not_run
[3]
review.human_critique
[4]
review.independent_reader
[5]
review.machine_critique
assays array · 1 item
[0] object · 11 fields
role
analysis
definition_id
group_comparison
definition_version
f2132e96ae6c7a4e
required_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Statistical analysis was performed using ProgenesisQI™ software; briefly transformed normalised abundances were used for one-way analysis of variance (ANOVA) and all peptides (with p < 0.05) of an identified protein were included.
order_basis
analysis_only
id
assay:1
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:28666451", "kind": "science-record", "revision": 8, "content_hash": "sha256:25a27d8fc49ad2af30885baa8bb7d3289d42000038900a08dc35d78b4a1ef3c8", "created_at": "2026-11-01T15:40:27Z", "updated_at": "2026-11-01T22:43:02Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Autologous chondrocyte implantation-derived synovial fluids display distinct responder and non-responder proteomic profiles.", "doi": "10.1186/s13075-017-1336-7", "pmid": "28666451", "authors": ["Charlotte H Hulme", "Emma L Wilson", "Mandy J Peffers", "Sally Roberts", "Deborah M Simpson", "James B Richardson", "Pete Gallacher", "Karina T Wright"], "journal": "Arthritis research & therapy", "year": 2017, "abstract": "BACKGROUND: Autologous chondrocyte implantation (ACI) can be used in the treatment of focal cartilage injuries to prevent the onset of osteoarthritis (OA). However, we are yet to understand fully why some individuals do not respond well to this intervention. Identification of a reliable and accurate biomarker panel that can predict which patients are likely to respond well to ACI is needed in order to assign the patient to the most appropriate therapy. This study aimed to compare the baseline and mid-treatment proteomic profiles of synovial fluids (SFs) obtained from responders and non-responders to ACI.\nMETHODS: SFs were derived from 14 ACI responders (mean Lysholm improvement of 33 (17-54)) and 13 non-responders (mean Lysholm decrease of 14 (4-46)) at the two stages of surgery (cartilage harvest and chondrocyte implantation). Label-free proteome profiling of dynamically compressed SFs was used to identify predictive markers of ACI success or failure and to investigate the biological pathways involved in the clinical response to ACI.\nRESULTS: Only 1 protein displayed a ≥2.0-fold differential abundance in the preclinical SF of ACI responders versus non-responders. However, there is a marked difference between these two groups with regard to their proteome shift in response to cartilage harvest, with 24 and 92 proteins showing ≥2.0-fold differential abundance between Stages I and II in responders and non-responders, respectively. Proteomic data has been uploaded to ProteomeXchange (identifier: PXD005220). We have validated two biologically relevant protein changes associated with this response, demonstrating that matrix metalloproteinase 1 was prominently elevated and S100 calcium binding protein A13 was reduced in response to cartilage harvest in non-responders.\nCONCLUSIONS: The differential proteomic response to cartilage harvest noted in responders versus non-responders is completely novel. Our analyses suggest several pathways which appear to be altered in non-responders that are worthy of further investigation to elucidate the mechanisms of ACI failure. These protein changes highlight many putative biomarkers that may have potential for prediction of ACI treatment success.", "claims": [{"id": "claim-method", "statement": "Statistical analysis was performed using ProgenesisQI™ software; briefly transformed normalised abundances were used for one-way analysis of variance (ANOVA) and all peptides (with p < 0.05) of an identified protein were included.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:28666451", "locator": "sections[6] \"Mass spectrometry and label-free quantification\" paragraph 2", "quote": "Statistical analysis was performed using ProgenesisQI™ software; briefly transformed normalised abundances were used for one-way analysis of variance (ANOVA) and all peptides (with p < 0.05) of an identified protein were included."}], "state": "complete"}, {"id": "claim-data-access", "statement": "Proteomic data has been deposited in the PRIDE ProteomeXchange and can be accessed using the identifier PXD005220.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:28666451", "locator": "sections[17] \"ack\" paragraph 1", "quote": "Proteomic data has been deposited in the PRIDE ProteomeXchange and can be accessed using the identifier PXD005220."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": "The study used Ingenuity pathway analysis with a right-sided Fisher’s exact test and an independent DAVID pathway analysis, while the underlying proteomic source data were deposited in PRIDE ProteomeXchange under identifier PXD005220.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:28666451"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD005220"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD005220"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:28666451", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1186/s13075-017-1336-7", "sha256": "sha256:c098eae219b4c813614ad855bcebd23e82a42d28d0f8493f76b2eef7501212f2", "bytes": 50158, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1186/s13075-017-1336-7", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC5493128", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:PXD005220", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD005220", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "PXD005220", "version": null, "note": "Proteomic data has been deposited in the PRIDE ProteomeXchange and can be accessed using the identifier PXD005220.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "Proteomic data has been deposited in the PRIDE ProteomeXchange and can be accessed using the identifier PXD005220.", "access_statement_kind": "data_availability_statement", "sample_accessions": [], "sample_count": null, "group_sizes": null, "group_sizes_basis": null, "platform": null, "taxon": null, "title": "Proteomic profiles of  synovial fluids derived from autologous chondrocyte implantation surgery", "resolution_checked_at": "2026-10-31T18:35:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:28666451:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:bc4afaf837a5d76c20b6ba7a8a43906f9d8bec36a19036c13386050a7233c8ea", "bytes": 1940, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[3]/table-wrap[1]#Tab1", "version": null, "note": "Demographic data for patient participants whose samples from Stage I or Stage II were analysed who responded clinically (responders) or who did not respond (non-responders) to autologous chondrocyte implantation (ACI)", "structure": {"pmcid": "PMC5493128", "section_index": 3, "section_title": "Synovial fluid collection and storage", "row_count": 16, "column_count": 7}, "table": {"label": "Table 1", "caption": "Demographic data for patient participants whose samples from Stage I or Stage II were analysed who responded clinically (responders) or who did not respond (non-responders) to autologous chondrocyte implantation (ACI)", "rows": [["", "Stage I", "Stage II", "p value (A) R v NR SI; (B) R v NR SI", "p value (A) SI v SII R; (B) SI v SII NR"], ["Responders (n = 8)", "Non-responders (n = 7)", "Responders (n = 12)", "Non-responders (n = 12)"], ["Difference in Lysholm Score", "27 (17–38)", "–8 (–4 to –17)", "34 (17–54)", "–11 (–4 to –46)", "(A) 0.0003; (B) <0.0001", "(A) 0.21; (B) 0.55"], ["BMI (kg/m2)", "29 (23–31)", "27 (24–31)", "27 (23–48)", "29 (22–36)", "(A) 0.94; (B) 0.54", "(A) 0.73; (B) 0.68"], ["Age (years)", "32 (17–49)", "40 (25–50)", "40 (17–90)", "43 (25–52)", "(A) 0.28; (B) 0.92", "(A) 0.17; (B) 0.58"], ["Male (n)", "8", "7", "11", "10", "(A) >0.99; (B) >0.99", "(A) >0.99; (B) 0.51"], ["Smoker (n)", "1", "2", "1", "3", "(A) 0.54; (B) 0.59", "(A) >0.99; (B) >0.99"], ["Dilution factor of SF", "5 (3–9)", "4 (2–7)", "4 (1–9)", "3 (2–5)", "(A) 0.48; (B) 0.25", "(A) 0.53; (B) 0.50"], ["Total defect area (cm2)", "14 (0.4–24)", "6 (0.6–12)", "6 (1–20)", "5 (0.6–12)", "(A) 0.74; (B) 0.35", "(A) 0.45; (B) 0.28"], ["Patella defect (n)", "1", "1", "4", "2", "(A) >0.99; (B) 0.64", "(A) 0.60; (B) >0.99"], ["LFC defect (n)", "2", "0", "0", "0", "(A) 0.47; (B) >0.99", "(A) 0.15; (B) >0.99"], ["LTP defect (n)", "1", "0", "0", "0", "(A) >0.99; (B) >0.99", "(A) 0.15; (B) >0.99"], ["MFC defect (n)", "2", "2", "1", "6", "(A) >0.99; (B) 0.07", "(A) 0.54; (B) 0.63"], ["Trochlea defect (n)", "0", "3", "2", "1", "(A) 0.20; (B) >0.99", "(A) 0.49; (B) 0.12"], ["Multiple defects (n)", "1", "0", "1", "1", "(A) >0.99; (B) >0.99", "(A) >0.99; (B) >0.99"], ["Unknown defect location (n)", "1", "1", "4", "2", "(A) >0.99; (B) 0.64", "(A) 0.60; (B) >0.99"]], "row_count": 16, "column_count": 7, "numeric_cells": 88, "header_rows": 2, "locator": "section[3]/table-wrap[1]#Tab1"}}, {"id": "asset:table:pmid:28666451:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:07b8c536a67e4cb2f70a7a828f3e6ff710462df9488e9ff9eba3142c1275cb21", "bytes": 5011, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[1]#Tab2", "version": null, "note": "Fold-change of proteins that are differentially expressed in the synovial fluid collected at Stage I compared to Stage II of the ACI procedure in clinical non-responders. Proteins shown in italic were validated using enzyme linked immunosorbant assay", "structure": {"pmcid": "PMC5493128", "section_index": 11, "section_title": "Differential abundance of proteins after controlled cartilage injury (Stage I versus Stage II)", "row_count": 91, "column_count": 3}, "table": {"label": "Table 2", "caption": "Fold-change of proteins that are differentially expressed in the synovial fluid collected at Stage I compared to Stage II of the ACI procedure in clinical non-responders. Proteins shown in italic were validated using enzyme linked immunosorbant assay", "rows": [["Protein", "Fold change"], ["Description", "Accession"], ["Perilipin-4", "Q96Q06", "–4.3"], ["Syntaxin-7", "O15400", "–3.9"], ["Fermitin family homolog 3", "Q86UX7", "–3.7"], ["Deoxynucleoside triphosphate triphosphohydrolase SAMHD1", "Q9Y3Z3", "–3.7"], ["PDZ and LIM domain protein 1", "O00151", "–3.6"], ["Sorting nexin-5", "Q9Y5X3", "–3.3"], ["Neuroblast differentiation-associated protein AHNAK", "Q09666", "–3.2"], ["Signal recognition particle 14 kDa protein", "P37108", "–3.0"], ["Hyaluronan and proteoglycan link protein 3", "Q96S86", "–3.0"], ["Heterogeneous nuclear ribonucleoprotein K", "P61978", "–2.9"], ["ATP-citrate synthase", "P53396", "–2.9"], ["Fatty acid-binding protein, epidermal", "Q01469", "–2.8"], ["60S ribosomal protein L12", "P30050", "–2.7"], ["Fatty acid-binding protein, adipocyte", "P15090", "–2.6"], ["Insulin-like growth factor-binding protein 6", "P24592", "–2.6"], ["Protein canopy homolog 3", "Q9BT09", "–2.6"], ["Tripeptidyl-peptidase 1", "O14773", "–2.5"], ["PDZ and LIM domain protein 3", "Q53GG5", "–2.5"], ["Cellular nucleic acid-binding protein", "P62633", "–2.5"], ["Bifunctional glutamate/proline-tRNA ligase", "P07814", "–2.5"], ["Protein disulfide-isomerase A3", "P30101", "–2.4"], ["Peroxiredoxin-6", "P30041", "–2.4"], ["Tryptase alpha/beta-1", "Q15661", "–2.4"], ["Endoplasmic reticulum resident protein 29", "P30040", "–2.4"], ["Peroxiredoxin-1", "Q06830", "–2.4"], ["Na(+)/H(+) exchange regulatory cofactor NHE-RF1", "O14745", "–2.4"], ["Mitochondrial import inner membrane translocase subunit TIM14", "Q96DA6", "–2.4"], ["Mortality factor 4-like protein 1", "Q9UBU8", "–2.4"], ["Fructose-bisphosphate aldolase A", "P04075", "–2.3"], ["Microtubule-associated protein RP/EB family member 1", "Q15691", "–2.3"], ["Leucine zipper transcription factor-like protein 1", "Q9NQ48", "–2.3"], ["Transcription elongation factor A protein 1", "P23193", "–2.3"], ["2',3'-cyclic-nucleotide 3'-phosphodiesterase", "P09543", "–2.3"], ["Histamine N-methyltransferase", "P50135", "–2.3"], ["Protein S100-A13", "Q99584", "–2.3"], ["Acrosomal protein SP-10", "P26436", "–2.2"], ["AP-2 complex subunit beta", "P63010", "–2.2"], ["S-phase kinase-associated protein 1", "P63208", "–2.2"], ["High mobility group protein B3", "O15347", "–2.2"], ["Cytokine-like protein 1", "Q9NRR1", "–2.2"], ["Mitochondrial fission 1 protein", "Q9Y3D6", "–2.2"], ["Filamin-A", "P21333", "–2.2"], ["Nuclear migration protein nudC", "Q9Y266", "–2.1"], ["Cathepsin K", "P43235", "–2.1"], ["Prostaglandin E synthase 3", "Q15185", "–2.1"], ["Vinculin", "P18206", "–2.1"], ["Plastin-2", "P13796", "–2.1"], ["Coronin-1C", "Q9ULV4", "–2.1"], ["Ig heavy chain V-I region V35", "P23083", "–2.1"], ["Stress-induced-phosphoprotein 1", "P31948", "–2.1"], ["Putative phospholipase B-like 2", "Q8NHP8", "–2.1"], ["Gelsolin", "P06396", "–2.0"], ["Spectrin beta chain, erythrocytic", "P11277", "–2.0"], ["Stathmin", "P16949", "–2.0"], ["Hsc70-interacting protein", "P50502", "–2.0"], ["40S Ribosomal protein", "P23396", "–2.0"], ["Epidermal growth factor receptor substrate 15", "P42566", "22.5"], ["Hemoglobin subunit theta-1", "P09105", "6.1"], ["C-type lectin domain family 11 member A", "Q9Y240", "5.6"], ["Periostin", "Q15063", "5.1"], ["Collagen alpha-1(I) chain", "P02452", "4.7"], ["Spectrin alpha chain, erythrocytic 1", "P02549", "4.0"], ["Collagen alpha-1(V) chain", "P20908", "3.7"], ["Fibrinogen gamma chain", "P02679", "3.5"], ["Collagen alpha-1(XII) chain", "Q99715", "3.3"], ["Complement C1q tumor necrosis factor-related protein 3", "Q9BXJ4", "3.1"], ["Adiponectin", "Q15848", "3.0"], ["Adipocyte enhancer-binding protein 1", "Q8IUX7", "3.0"], ["Latent-transforming growth factor beta-binding protein 1", "Q14766", "3.0"], ["Fibrinogen beta chain", "P02675", "3.0"], ["Chondroitin sulfate proteoglycan 4", "Q6UVK1", "2.9"], ["Fibrinogen alpha chain", "P02671", "2.8"], ["Interstitial collagenase (MMP1)", "P03956", "2.7"], ["Secreted phosphoprotein 24", "Q13103", "2.7"], ["Collagen alpha-2(V) chain", "P05997", "2.6"], ["Ferritin light chain", "P02792", "2.6"], ["C4b-binding protein alpha chain", "P04003", "2.6"], ["Nucleobindin-1", "Q02818", "2.4"], ["C4b-binding protein beta chain", "P20851", "2.2"], ["Vitamin K-dependent protein S", "P07225", "2.2"], ["Fibronectin", "P02751", "2.2"], ["Prosaposin", "P07602", "2.1"], ["Integrin beta-like protein 1", "O95965", "2.1"], ["Adipocyte plasma membrane-associated protein", "Q9HDC9", "2.1"], ["Cytoplasmic dynein 1 heavy chain 1", "Q14204", "2.0"], ["Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D", "A1L4H1", "2.0"], ["F-actin-capping protein subunit beta", "P47756", "2.0"], ["Mannan-binding lectin serine protease 1", "P48740", "2.0"], ["Thrombospondin-3", "P49746", "2.0"]], "row_count": 91, "column_count": 3, "numeric_cells": 220, "header_rows": 2, "locator": "section[11]/table-wrap[1]#Tab2"}}, {"id": "asset:table:pmid:28666451:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:7aa5cdfc8280ec6a4158f1aa502218a473efd4500b5f6ef865567c4299dbb959", "bytes": 1577, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[2]#Tab3", "version": null, "note": "Proteins that are differentially expressed with a ≥2.0-fold-change in the synovial fluid collected at Stage I compared to Stage II of the ACI procedure in clinical responders", "structure": {"pmcid": "PMC5493128", "section_index": 11, "section_title": "Differential abundance of proteins after controlled cartilage injury (Stage I versus Stage II)", "row_count": 26, "column_count": 3}, "table": {"label": "Table 3", "caption": "Proteins that are differentially expressed with a ≥2.0-fold-change in the synovial fluid collected at Stage I compared to Stage II of the ACI procedure in clinical responders", "rows": [["Protein", "Fold change"], ["Description", "Accession"], ["Heat shock protein 75 kDa, mitochondrial", "Q12931", "–470.0"], ["Microtubule-associated protein 1B", "P46821", "–17.2"], ["Adenosylhomocysteinase", "P23526", "–3.7"], ["Complement factor H-related protein 3", "Q02985", "–2.8"], ["Mannose-1-phosphate guanyltransferase beta", "Q9Y5P6", "–2.7"], ["Peroxiredoxin-4", "Q13162", "–2.5"], ["Oxysterol-binding protein 1", "P22059", "–2.4"], ["Protein canopy homolog 3", "Q9BT09", "–2.1"], ["Spermatid perinuclear RNA-binding protein", "Q96SI9", "–2.0"], ["Ferritin light chain", "P02792", "2.2"], ["Secreted phosphoprotein 24", "Q13103", "2.2"], ["Chondroitin sulfate proteoglycan 4", "Q6UVK1", "2.3"], ["Collagen alpha-2(I) chain", "P08123", "2.3"], ["Collagen alpha-1(V) chain", "P20908", "2.5"], ["26S protease regulatory subunit 6A", "P17980", "2.7"], ["Collagen alpha-2(V) chain", "P05997", "2.9"], ["Collagen alpha-1(I) chain", "P02452", "3.3"], ["Spectrin alpha chain, erythrocytic 1", "P02549", "4.1"], ["Histidine triad nucleotide-binding protein 1", "P49773", "4.2"], ["Platelet factor 4", "P02776", "4.2"], ["Alpha-1-acid glycoprotein 2", "P19652", "4.3"], ["Protein 4.1", "P11171", "4.3"], ["Periostin", "Q15063", "4.5"], ["26S proteasome non-ATPase regulatory subunit 13", "Q9UNM6", "4.6"]], "row_count": 26, "column_count": 3, "numeric_cells": 65, "header_rows": 2, "locator": "section[11]/table-wrap[2]#Tab3"}}, {"id": "asset:table:pmid:28666451:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:2199179b97fa41a5fd60b7dcf5cfc145981c31f82a8e5150228d816341d5dbaf", "bytes": 2352, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[12]/table-wrap[1]#Tab4", "version": null, "note": "Analysis of upstream regulators of interactome networks generated from protein changes between Stages I (SI) and II (SII) in either responders or non-responders to ACI were identified using Ingenuity Pathway Analysis software", "structure": {"pmcid": "PMC5493128", "section_index": 12, "section_title": "Identification of canonical pathways and protein networks associated with protein changes between Stage I and II", "row_count": 23, "column_count": 5}, "table": {"label": "Table 4", "caption": "Analysis of upstream regulators of interactome networks generated from protein changes between Stages I (SI) and II (SII) in either responders or non-responders to ACI were identified using Ingenuity Pathway Analysis software", "rows": [["Upstream regulators", "Activation z score (SII v SI)", "p value of overlap", "Target molecules in dataset"], ["Non-responders"], ["", "TGFB1", "–1.595", "9.46E–10", "APOB,APOC2,APOE,CD44,COL1A1,COL1A2,COL5A1,COMP,CSPG4,CTSD,ECM1,FETUB,FN1,FTL,GSN,HINT1,HSPG2,HTRA1,IGFBP6,LCAT,MYLK,PCOLCE2,PDXK,POSTN,RAP1A,S100A4,TGFBI"], ["DYSF", "NP", "2.01E–09", "CFD,FN1,FTL,LCP1,LYZ,PROS1,S100-A13,S100A4"], ["MYC", "3.046", "2.20E–09", "ALDOA,ANXA5,CCT3,CD44,COL1A1,COL1A2,COL5A1,CSPG4,CTSD,ECM1,FN1,HSPA9,LYZ,NCL,NUCB1,NUDC,PAM,PTN,RPL22,RPL30,TF"], ["COL9A1", "1.308", "2.79E–09", "COMP,FN1,HSPG2,TGFBI,THBS4"], ["Beta-estradiol", "2.271", "5.01E–09", "ALDOA,APOE,CD44,COL1A1,COL1A2,COMP,CTSD,F7,FN1,GMFB,HSPA2,HSPA8,HSPA9,HTRA1,IGFBP6,LTF,LYZ,MYLK,PAM,PDIA3,QSOX1,RAP1A,RPS13,S100-A13,SLC9A3R1,TF,THBS4"], ["Lipopolysaccharide", "–0.104", "5.96E–09", "ANXA5,APOB,APOC2,APOE,CD44,CFD,COL1A1,COL1A2,COL5A1,CSPG4,FN1,GSN,HDGFRP3,HMGB2,HSPA8,HTRA1,ITIH2,LBP,LTF,LYZ,PARK7,PCOLCE,PCOLCE2,PDIA3,PLG,TF"], ["Dihydrotestosterone", "–1.091", "1.03E–08", "ALDOA,APOE,CCT3,FN1,FTL,GSN,HINT1,LYZ,MYLK,NUCB1,PAM,POSTN,PROS1,RPL30,TF"], ["HRAS", "0.623", "2.52E–08", "CD44,COL1A1,COL1A2,ERP29,FN1,GSN,HSPA8,HTRA1,LYZ,MYH10,PDIA5,PLTP,POSTN,RPL30,S100A4"], ["KRAS", "2.226", "3.99E–08", "ALDOA,CD44,COL1A1,FN1,GBA,GSN,MYLK,PCOLCE,PDIA3,PSMA7,RNASE4,S100A4"], ["SMARCB1", "–1.195", "4.82E–08", "APOC4,CD44,COL1A1,COL1A2,GSN,LBP,POSTN,PTN,RAB14"], ["Responders"], ["", "CEBPB", "–1.067", "2.03E–07", "APOB,CFD,COL1A1,COL1A2,F7,HSPA8,PLG"], ["FLI1", "NP", "3.82E–07", "COL1A1,COL1A2,HSPA8,PF4"], ["S-adenosylhomocysteine", "NP", "1.21E–06", "COL1A1,COL1A2"], ["SCX", "NP", "1.65E–06", "COL1A1,COMP,POSTN"], ["Tgf beta (group)", "–1.454", "5.16E–06", "COL1A1,COL1A2,LCAT,POSTN,TGFBI"], ["ENTPD5", "NP", "1.21E–05", "COL1A1,COL1A2"], ["MKX", "NP", "1.21E–05", "COL1A1,COL1A2"], ["GATA4", "NP", "2.86E–05", "COL1A1,COL1A2,POSTN,TGFBI"], ["Nilotinib", "NP", "3.39E–05", "COL1A1,COL1A2"], ["TBX5", "NP", "5.50E–05", "COL1A1,COL1A2,POSTN"]], "row_count": 23, "column_count": 5, "numeric_cells": 40, "header_rows": 1, "locator": "section[12]/table-wrap[1]#Tab4"}}], "gaps": ["asset:data:geo:PXD005220 not downloaded", "asset:data:geo:PXD005220 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "group_comparison", "specific": "anova", "label": "Group comparison", "dsl_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Statistical analysis was performed using ProgenesisQI™ software; briefly transformed normalised abundances were used for one-way analysis of variance (ANOVA) and all peptides (with p < 0.05) of an identified protein were included."}}, {"id": "method-2", "family": "network_analysis", "specific": "pathway_enrichment", "label": "Network / pathway analysis", "dsl_operations": ["pathway_enrich"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["edge_list"], "evidence": {"score": 0.8, "band": "high", "quote": "pathway enrichment"}}], "targets": [{"id": "target-published-estimate", "claim_id": "claim-target-result", "operation": "bootstrap_mean_difference", "expected_value": 2.1, "unit": "p-value", "tolerance": null, "state": "complete", "note": "The threshold the paper applied to its own result, as the paper states it. A run that reproduces the effect is judged against this threshold."}], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: anova."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["PXD005220"], "resolved_accessions": ["PXD005220"], "statements": ["Proteomic data has been deposited in the PRIDE ProteomeXchange and can be accessed using the identifier PXD005220."], "basis": "The paper names PXD005220 in PRIDE ProteomeXchange and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "assets": ["source:pmid:28666451", "data:geo:PXD005220", "asset:table:pmid:28666451:1", "asset:table:pmid:28666451:2", "asset:table:pmid:28666451:3", "asset:table:pmid:28666451:4"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:PXD005220"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:31:28Z", "independence": "same_provider"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 8, "usage": {"prompt_tokens": 105032, "completion_tokens": 2881, "cached_tokens": 2088}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:28666451", "type": "paper", "label": "pmid:28666451"}, {"id": "source:pmid:28666451", "type": "manuscript", "label": "PMID 28666451 full text"}, {"id": "data:geo:PXD005220", "type": "dataset", "label": "GEO PXD005220"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:28666451", "type": "paper", "label": "pmid:28666451"}, {"id": "source:pmid:28666451", "type": "manuscript", "label": "PMID 28666451 full text"}, {"id": "data:geo:PXD005220", "type": "dataset", "label": "GEO PXD005220"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-28666451", "type": "extraction", "used": ["source:pmid:28666451"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-PXD005220", "type": "accession_resolution", "used": ["data:geo:PXD005220"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:28666451", "parent_hash": "sha256:06d57e8314c43768ce1fa11cdd5e00434978fd45123cab063d0ed06530f36a16", "fork_of": null, "generation": 7}, "gaps": ["asset:data:geo:PXD005220 licence not read", "asset:data:geo:PXD005220 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "analysis", "definition_id": "group_comparison", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["Statistical analysis was performed using ProgenesisQI™ software; briefly transformed normalised abundances were used for one-way analysis of variance (ANOVA) and all peptides (with p < 0.05) of an identified protein were included."], "order_basis": "analysis_only", "id": "assay:1"}]}